Uro Vaks - immunostimulant drug bacterial origin.
Structure and Composition
The drug release
in the form of hard gelatin capsules with yellow opaque body and opaque lid orange. One capsule contains active component: the lyophilized bacterial lysate 18 strains (Escherichia coli 6 mg).
Additional components: pregelatinized starch, propyl, gelatin, colorants, sodium stearate, sodium glutamate, mannitol.
The blister packs of 10 capsules.
The analogue Uro Vaksoma is bacterial lysates (Escherichia coli).
According to the instructions Uro Vaks has the following properties:
- It stimulates the production of endogenous interferon;
- It stimulates T-lymphocytes;
- increases the concentration of IgA.
According to clinical trials, the drug reduces the rate of recurrence of infections of the urinary tract, including cystitis.
Indications for use Uro Vaksoma
According to the instructions Uro Vaks administered in a combination therapy for the prevention and treatment of recurrent chronic infections of the urinary tract, especially cystitis, regardless of the source organism.
In the opinion of Uro Vaks usually prescribed in conjunction with antibiotics and other antimicrobial drugs for children over four years and adults.
The drug is contraindicated in case of hypersensitivity to take one or more components.
Dosing Uro Vaksoma and dosing regimen
For therapeutic purposes,
drug taking one capsule daily on an empty stomach as an additional drug therapy in combination with conventional antimicrobial therapy until symptoms disappear. Duration of generally not less than ten days. The maximum treatment time - three months.
As a preventive measure against recurrence of a chronic infection of the urinary tract take one capsule every morning on an empty stomach for three months.
Side effects Uro Vaksoma
In the opinion of Uro Vaks well tolerated by patients. Occasionally you may experience the following side effects:
- Dermatological reactions: erythema, itching, eczema.
- Digestive system: diarrhea, vomiting, nausea.
- Other side effects: a slight fever.
In rare cases, allergic skin reactions limited.
No reviews Uro Vaksome regarding overdose has been reported. The nature of the preparation and the results obtained in the study of toxicity in animals indicate that an overdose is unlikely.
Application Uro Vaksoma during pregnancy and breastfeeding
During experimental studies studying reproduction is no danger to the fetus have been identified.
Regarding the use of the drug or analogue Uro Vaksoma during pregnancy no information.
Drug interaction Uro Vaksoma
It is recommended to take precautions and to refuse to accept the drug for two weeks before and two weeks after the internal use of live vaccines.
In effect Uro Vaksoma can influence immunosuppressive drugs.
The preparation is stored at room temperature for more than five years.